Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 97401-97450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03525951
Parent-Level Predictors of Early Language Interaction Quality and Intervention Outcomes
NARecruiting
300 participants
Started: Mar 22, 2021 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT05867355
Surgically Treated Displaced Mid-diaphyseal Clavicle Fractures
N/ARecruiting
111 participants
Started: Mar 22, 2021 · Completed: Dec 1, 2025
1 condition6 sponsors1 location
NCT04620239
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
PHASE3Recruiting
100 participants
Started: Mar 22, 2021 · Completed: Jan 25, 2029
1 condition3 sponsors22 locations
NCT05058612
Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)
PHASE4Recruiting
870 participants
Started: Mar 22, 2021 · Completed: Feb 29, 2028
1 condition4 sponsors1 location
NCT04827368
Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease
N/AActive, not recruiting
292 participants
Started: Mar 22, 2021 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT04965155
A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)
PHASE2Active, not recruiting
50 participants
Started: Mar 21, 2021 · Completed: Mar 31, 2027
1 condition1 sponsor14 locations
NCT04727788
Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection
N/AActive, not recruiting
550 participants
Started: Mar 21, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor13 locations
NCT04940585
ROSE in Sunset Park
NARecruiting
117 participants
Started: Mar 21, 2021 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05053802
Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
PHASE2Recruiting
146 participants
Started: Mar 21, 2021 · Completed: Sep 30, 2027
1 condition1 sponsor6 locations
NCT04790344
LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
NAActive, not recruiting
525 participants
Started: Mar 20, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor56 locations
NCT04902781
Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia
PHASE2/PHASE3Active, not recruiting
47 participants
Started: Mar 20, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor3 locations
NCT04793334
Underlying Mechanisms of Obesity-induced Obstructive Sleep Apnea
N/AEnrolling by invitation
110 participants
Started: Mar 20, 2021 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT04628663
Effects of Dexmedetomidine on Intraocular Pressure During Scheduled Spine Surgeries
NARecruiting
60 participants
Started: Mar 20, 2021 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04833348
Quantification of Motor Function in Infants With Spinal Muscular Atrophy Treated With Innovative Therapies
NAActive, not recruiting
35 participants
Started: Mar 20, 2021 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05133102
Longitudinal Oral Microbiome Sampling for BE
N/ARecruiting
275 participants
Started: Mar 19, 2021 · Completed: Aug 31, 2026
1 condition3 sponsors2 locations
NCT07107607
Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)
N/ARecruiting
50 participants
Started: Mar 19, 2021 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05504499
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
NARecruiting
100 participants
Started: Mar 19, 2021 · Completed: Jan 1, 2028
1 condition1 sponsor10 locations
NCT04565431
Examining Effects of Tysabri on Cognitive Fatigue Using fMRI
N/ARecruiting
25 participants
Started: Mar 19, 2021 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04847258
Rate of Non-copers to Non-surgical ACL Treatment After 3 Months of Rehabilitation
N/ARecruiting
357 participants
Started: Mar 19, 2021 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT04621188
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
PHASE2Active, not recruiting
54 participants
Started: Mar 19, 2021 · Completed: Feb 28, 2027
1 condition1 sponsor34 locations
NCT04653064
The Warmth, Anticipation, Sensation, Aversion, and Body-part Imaging Study
NARecruiting
150 participants
Started: Mar 19, 2021 · Completed: Dec 26, 2025
1 condition1 sponsor1 location
NCT04760717
Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
PHASE2Recruiting
200 participants
Started: Mar 19, 2021 · Completed: Dec 31, 2025
3 conditions2 sponsors5 locations
NCT04843176
Artificial Intelligence vs. LIRADS in Diagnosing HCC on CT
NARecruiting
250 participants
Started: Mar 19, 2021 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT04809181
Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients
PHASE2Recruiting
95 participants
Started: Mar 19, 2021 · Completed: Mar 19, 2026
2 conditions12 sponsors1 location
NCT04455841
INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
PHASE1/PHASE2Active, not recruiting
84 participants
Started: Mar 19, 2021 · Completed: Nov 26, 2027
3 conditions1 sponsor34 locations
NCT04799054
A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Active, not recruiting
188 participants
Started: Mar 18, 2021 · Completed: Mar 31, 2026
7 conditions1 sponsor49 locations
NCT04896177
Sirolimus DEB in Coronary Bifurcation Lesions
NARecruiting
280 participants
Started: Mar 18, 2021 · Completed: Sep 18, 2026
1 condition1 sponsor1 location
NCT04784247
Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma
PHASE2Active, not recruiting
52 participants
Started: Mar 18, 2021 · Completed: Mar 31, 2026
1 condition3 sponsors7 locations
NCT04855123
Evaluation of the Degradation of Renal Function Post Nephrectomy According to Retinal Vascularisation Parameters
NARecruiting
42 participants
Started: Mar 18, 2021 · Completed: Mar 31, 2025
2 conditions1 sponsor1 location
NCT04812912
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
N/ARecruiting
120 participants
Started: Mar 18, 2021 · Completed: Mar 18, 2026
3 conditions1 sponsor8 locations
NCT04791033
Quality of Life After Hysterectomy (AdenoQOL)
N/AActive, not recruiting
218 participants
Started: Mar 18, 2021 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT04677049
Study of Niacin in Glioblastoma
PHASE1/PHASE2Recruiting
59 participants
Started: Mar 18, 2021 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT04823143
Natural History Study of Patients With VCP-related Disease
N/AActive, not recruiting
44 participants
Started: Mar 18, 2021 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT04691804
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE3Active, not recruiting
496 participants
Started: Mar 18, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor147 locations
NCT04387227
Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2Active, not recruiting
22 participants
Started: Mar 18, 2021 · Completed: Jun 1, 2026
3 conditions3 sponsors1 location
NCT04837716
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer
PHASE1Active, not recruiting
12 participants
Started: Mar 18, 2021 · Completed: Sep 23, 2027
6 conditions1 sponsor1 location
NCT05360706
Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B
N/AActive, not recruiting
9 participants
Started: Mar 18, 2021 · Completed: May 31, 2026
1 condition1 sponsor6 locations
NCT04586530
Telehealth and Memory Study
NAActive, not recruiting
220 participants
Started: Mar 18, 2021 · Completed: May 31, 2026
1 condition2 sponsors2 locations
NCT04798079
Systems Biology of Early Atopy
N/ARecruiting
2,500 participants
Started: Mar 18, 2021 · Completed: Mar 31, 2032
3 conditions3 sponsors12 locations
NCT04951635
A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer
PHASE3Recruiting
150 participants
Started: Mar 18, 2021 · Completed: Jan 15, 2027
1 condition1 sponsor1 location
NCT04102475
Efficacy of a Phone-based Relapse Prevention for Anorexia Nervosa After a First Hospitalization
NARecruiting
270 participants
Started: Mar 18, 2021 · Completed: Mar 31, 2026
1 condition2 sponsors6 locations
NCT05145725
Instrumented POsterolateral Arthrodesis for Adolescent Idiopathic Scoliosis
N/ARecruiting
866 participants
Started: Mar 18, 2021 · Completed: Mar 18, 2036
2 conditions3 sponsors1 location
NCT05417334
Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 9 Months Postpartum.
NARecruiting
110 participants
Started: Mar 18, 2021 · Completed: Jan 31, 2024
1 condition1 sponsor1 location
NCT04574778
Randomized Trial of Intraoperative IV Versus Preoperative Oral Acetaminophen During Ambulatory Lumbar Discectomy
PHASE3Recruiting
82 participants
Started: Mar 18, 2021 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT04664465
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
N/ARecruiting
300 participants
Started: Mar 18, 2021 · Completed: Mar 18, 2026
6 conditions1 sponsor11 locations
NCT04819308
Differences in Nutrient Use During Exercise Between Children of Varying Body Mass Indices and Fitness Levels
N/AActive, not recruiting
95 participants
Started: Mar 18, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04756037
Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
PHASE3Active, not recruiting
1,020 participants
Started: Mar 18, 2021 · Completed: Feb 28, 2026
1 condition1 sponsor112 locations
NCT04356664
Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
PHASE2/PHASE3Recruiting
180 participants
Started: Mar 18, 2021 · Completed: Jun 18, 2026
3 conditions1 sponsor1 location
NCT04586010
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
PHASE3Active, not recruiting
746 participants
Started: Mar 17, 2021 · Completed: Nov 30, 2027
1 condition1 sponsor160 locations
NCT04550104
A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
PHASE1Recruiting
200 participants
Started: Mar 17, 2021 · Completed: Mar 31, 2028
1 condition11 sponsors11 locations